Evidence map›Paper›PMID 31391273›Full record

ArticleJournal of virology2019

A CRISPR Screen Identifies the Cell Polarity Determinant Crumbs 3 as an Adeno-associated Virus Restriction Factor in Hepatocytes.

Victoria J Madigan, Tyne O Tyson, Julianne A Yuziuk, Minakshi Pillai, Sven Moller-Tank, Aravind Asokan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  3. Casein kinase 2 activity is a host restriction factor for AAV transduction.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  4. Review
  5. Article
  6. Tight Junctions, the Key Factor in Virus-Related Disease.Pathogens (Basel, Switzerland) · 2022
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Victoria J MadiganCurriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Tyne O TysonDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
Julianne A YuziukGene Therapy Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Minakshi PillaiGene Therapy Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Sven Moller-TankGene Therapy Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Aravind AsokanDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina, USA aravind.asokan@duke.edu.
Duke University · USUniversity of North Carolina at Chapel Hill · US

Funding

Determinants of AAV TropismR01HL089221 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Aravind Asokan · 2009 to 2026
$8.1M
RE-ENGINEERING AAV GENOME PACKAGINGR01GM127708 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ASOKAN, ARAVIND · 2018 to 2021
$2.0M
NHLBI NIH HHS R01 HL089221NIGMS NIH HHS R01 GM127708
6 · The paper itself

Abstract

Adeno-associated viruses (AAV) are helper-dependent parvoviruses that have been developed into promising gene therapy vectors. Many studies, including a recent unbiased genomic screen, have identified host factors essential for AAV cell entry, but no genome-wide screens that address inhibitory host factors have been reported. Here, we utilize a novel CRISPR screen to identify AAV restriction factors in a human hepatocyte cell line. The major hit from our gain-of-function screen is the apical polarity determinant Crumbs 3 (Crb3). Knockout (KO) of Crb3 enhances AAV transduction, while overexpression exerts the opposite effect. Further, Crb3 appears to restrict AAV transduction in a serotype- and cell type-specific manner. Particularly, for AAV serotype 9 and a rationally engineered AAV variant, we demonstrate that increased availability of galactosylated glycans on the surfaces of Crb3 KO cells, but not the universal AAV receptor, leads to increased capsid attachment and enhanced transduction. We postulate that Crb3 could serve as a key molecular determinant that restricts the availability of AAV glycan attachment factors on the cell surface by maintaining apical-basal polarity and tight junction integrity.

Indexed as

CapsidCell LineCell MembraneCell PolarityClaudinsCRISPR-Cas SystemsDependovirusGene ExpressionGene Knockout TechniquesHepatocytesHumansMembrane GlycoproteinsParvoviridae InfectionsPolysaccharidesSerogroupTight Junctionsclaudin 15ClaudinsCRB3 protein, humanMembrane GlycoproteinsPolysaccharidesAdeno-associated viruscarbohydratecell polarityCRISPRparvovirusreceptor

Identifiers

PMID31391273
PMCPMC6803288
OpenAlexW2967405880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.